SCHEMBL2366099

SCHEMBL2366099

CCC1CNC(=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2842675 1.00
SCHEMBL2281276 1.00
SCHEMBL5450456 0.83
SCHEMBL12564801 0.81 ALDH1A1 (0.50)
SCHEMBL5452024 0.81 LMNA (0.45)
SCHEMBL28843423 0.80 LMNA (0.43)
SCHEMBL4578719 0.79
SCHEMBL16889153 0.78
Hexane SCHEMBL17769241 0.78 PTPN1 (0.43)
SCHEMBL19341995 0.78 LMNA (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885941-B1 Ink jet inks containing oxazolidinones XEROX CORP (US) 2004-02-18 EP claimed
US-5882389-A WATER, COLOR AND OXAZOLIDINONE XEROX CORPORATION (US) 1999-03-16 US claimed
EP-0885941-A1 Ink jet inks containing oxazolidinones Xerox Corporation (US) 1998-12-23 EP claimed
US-4462865-A Delignification of lignocellulosic materials with 2-imidazolidinones and 2-oxazolidinones THE DOW CHEMICAL COMPANY (US) 1984-07-31 US claimed
WO-2024101336-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND 国立大学法人京都大学 2024-05-16 WO disclosed
CN-117986245-A Detection reagent for metal alkoxide, preparation and application thereof 北京瑞博奥医药科技有限公司 2024-05-07 CN disclosed
US-11787788-B2 Benzimidazole derivatives, and pharmaceutical compositions and methods of use thereof CAPELLA THERAPEUTICS, INC. (US) 2023-10-17 US disclosed
US-20230271938-A1 BENZIMIDAZOLES FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES CAPELLA THERAPEUTICS, INC. 2023-08-31 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
EP-3119762-B9 BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER CAPELLA THERAPEUTICS INC (US) 2021-10-20 EP disclosed
US-11028093-B2 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors ARRAY BIOPHARMA INC. (US) 2021-06-08 US disclosed
EP-3119762-B1 BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER CAPELLA THERAPEUTICS INC (US) 2021-05-26 EP disclosed
US-4232162-A P-Substituted N,N'-bis-(3-oxazolidinyl-2-one)phosphoramides and process for the preparation thereof ANTIBIOTICS, S.A. (ES) 1980-11-04 US disclosed
US-4230849-A Process for the activation of carboxylic acids ANTIBIOTICOS, S.A. (ES) 1980-10-28 US disclosed
US-4058462-A System for sustained release of phenolic material from porous granules of insoluble polymeric phenolic complexes GAF CORPORATION (US) 1977-11-15 US disclosed
US-4000293-A METHOD OF INHIBITING BACTERIAL GROWTH WITH CERTAIN SELECTED 3-CHLORO-2-OXAZOLIDINONES INTERX RESEARCH CORPORATION (US) 1976-12-28 US disclosed
US-3985540-A Metal complexes of hydroxyquinoline and polymeric porous granules GAF CORPORATION (US) 1976-10-12 US disclosed
US-3970606-A N-vinyl lactam interpolymers useful as thickening agents GAF CORPORATION (US) 1976-07-20 US disclosed
US-3954682-A GRANULES OR BEADS GAF CORPORATION (US) 1976-05-04 US disclosed
US-3931213-A BACTERICIDE INTERX RESEARCH CORPORATION (US) 1976-01-06 US disclosed